FRED ROMEO: Open Payments
NPI 1568403814 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515,079 in 451 payments from 6 companies in 2025. Trend: 2023 $406,809 · 2024 $445,038 · 2025 $515,079
Speaker / faculty: $321,675Honoraria: $83,300Travel & lodging: $75,791Consulting: $23,930Food & beverage: $10,383
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 107 | $120,996 |
| E.R. Squibb & Sons, L.L.C. | 102 | $106,950 |
| Axsome Therapeutics, Inc. | 83 | $97,862 |
| Teva Pharmaceuticals USA, Inc. | 65 | $87,019 |
| Otsuka America Pharmaceutical, Inc. | 56 | $66,230 |
| Alkermes, Inc. | 38 | $36,022 |
Products named: CAPLYTA, Auvelity, COBENFY, REXULTI, AUSTEDO XR, LYBALVI, UZEDY.
Industry payments across OH — which companies pay providers there.
